West Pharmaceutical Services shares surge 19% following upgraded 2024 outlook
West Pharmaceutical Services Inc. (NYSE: WST) witnessed a significant 19% jump in its share price after it revised its fiscal 2024 outlook, citing stronger-than-expected performance. The company, a global leader in injectable drug administration solutions, raised its revenue projections for the year, buoyed by robust demand and strategic product launches. The firm’s shares surged to […]